RxDoctor Payments Data

Andraya Gower, MD

Dermatology · Oklahoma City, OKNPI 1235636200

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations.

$5,791in general payments, 2019–2025

Across 213 payments — averaging $27.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$757
  • UCB, Inc.$721
  • Johnson & Johnson$571
  • Novartis$467
  • LEO Pharma Inc.$413
  • Arcutis Biotherapeutics, Inc.$359
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$5,54296%
  • Education$2494%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,791 in reported general payments places this provider in the 55th percentile of 114 dermatology providers in Oklahoma.

See all dermatology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$790,479
Medicare patients
840
Services billed
7,421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab14$52,186
Clobetasol Propionate120$4,613
Fluorouracil40$2,918
Ketoconazole127$2,375
Tacrolimus22$1,433
Clindamycin Phosphate45$1,378
Triamcinolone Acetonide124$1,094
Metronidazole15$649
Fluocinonide16$561
Doxycycline Hyclate34$518
Hydrocortisone88$494
Cephalexin40$405
Betamethasone Dipropionate11$341
ValacyclovirValacyclovir Hcl19$254
Mupirocin24$244

Paid to pharmacies, not to this prescriber.

Other dermatology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →